14- Sedative-Hypnotics/Anti-anxiety Agents Flashcards
zolpidem (Ambien)
non-benzodiazepine
act between alpha or gamma site on GABAa receptor
-enhance GABA effect by increasing Cl- influx and increase frequency of GABA receptor opening
-plasma levels peak within 1-2 hours
-1/2 life 1.5-3 hours
-Metabolized by CYP3A4
zaleplon (Sonata)
non-benzodiazepine
act between alpha & gamma site on GABA receptor
-enhance GABA effect by increasing Cl- influx and increase frequency of GABA receptor opening
-plasma levels peak within 1-2 hours
-1/2 life 1.5-3 hours
-Metabolized by CYP3A4
eszopiclone (Lunesta)
non-benzodiazepine
act between alpha & gamma site on GABA receptor
-enhance GABA effect by increasing Cl- influx and increase frequency of GABA receptor opening
-plasma levels peak within 1-2 hours
-1/2 life 1.5-3 hours
-Metabolized by CYP3A4
diazepam (Valium)
Benzodiazepine
- bind between alpha and gamma subunit of GABAa receptors in limbic system to enhance GABA inhibition (produces anxiolytic effects)
- inc. FREQUNCY of GABA channel opening leading to greater Cl- influx and hyperpolarization
- BDZs cannot open GABAa receptor in the absence of GABA
- Prodrug metabolized to desmethyldiazepam which has active effects (extensive CYP metabolism)
- short onset (1-2 hrs), long half-life (30-60 hrs)
chlordiazepoxide (Librium)
Benzodiazepine
- bind between alpha & gamma subunit of GABAa receptors in limbic system to enhance GABA inhibition (produces anxiolytic effects)
- inc. FREQUNCY of GABA channel opening leading to greater Cl- influx and hyperpolarization
- BDZs cannot open GABAa receptor in the absence of GABA
- Prodrug metabolized to active form via phase 1 metabolism
- Extensive CYP metabolism
alprazolam (Xanax)
Benzodiazepine
- bind between alpha & gamma subunit of GABAa receptors in limbic system to enhance GABA inhibition (produces anxiolytic effects)
- inc. FREQUNCY of GABA channel opening leading to greater Cl- influx and hyperpolarization
- BDZs cannot open GABAa receptor in the absence of GABA
- Prodrug metabolized to active alpha-hydroxy metabolites via Phase 1 metabolism (extensive CYP metabolism)
- short onset (1-2 hrs); short half-life (12-15 hrs)
lorazepam (Ativan)
Benzodiazepine
- bind between alpha & gamma subunit of GABAa receptors in limbic system to enhance GABA inhibition (produces anxiolytic effects)
- inc. FREQUNCY of GABA channel opening leading to greater Cl- influx and hyperpolarization
- BDZs cannot open GABAa receptor in the absence of GABA
- onset 1-6 hrs; intermediate half-life (10-18 hrs)
midazolam (Versed)
Benzodiazepine
- bind between alpha & gamma subunit of GABAa receptors in limbic system to enhance GABA inhibition (produces anxiolytic effects)
- inc. FREQUNCY of GABA channel opening leading to greater Cl- influx and hyperpolarization
- BDZs cannot open GABAa receptor in the absence of GABA
- Extensive CYP metabolism
- Rapid onset (0.2-1 hr); ultra-short half-life (2-5 hrs)
flumazenil (Romazicon)
Benzodiazepine Antagonist
- blocks the effects of GABA agonists
- competitive inhibition of BZD binding site (gamma subunit)
- used to reverse s/fx of BZDs
- may need to be redosed because half-life is shorter than BZDs
pentobarbital (Nembutal)
GABA-A receptor agonist
-binds beta subunit on GABAa receptor in RAS and cortex
+increase open time of receptor and leads to hyperpolarization.
+at high concentrations it acts as GABAnergic (it can open channel without GABA).
-Works in the reticular formation (pons and medulla) which controls: somatic motor control, CV control, pain modulation, sleep and consciousness.
-Quick onset (0.5-1H); t1/2 elimination 15-50’
- used for preoperative sedation.
-metabolized by CYP’s and induces CYP metabolism
-more severe S/E, withdraw,and dependence than benzo
-potent respiratory depressant
phenobarbital (Luminal)
GABA-A receptor agonist
-binds beta subunit on GABAa receptor in RAS and cortex
+increase open time of receptor and leads to hyperpolarization.
+at high concentrations it acts as GABAnergic (it can open channel without GABA).
-Works in the reticular formation (pons and medulla) which controls: somatic motor control, CV control, pain modulation, sleep and consciousness.
- used as anticonvulsant.
-metabolized by CYP’s and induces CYP metabolism
-more severe S/E, withdraw,and dependence than benzo
-potent respiratory depressant
propranolol (Inderal)
miscellaneous antianxiety
- beta-receptor blocker
- blocks effects of epi which dec. HR, BP, sweating and shaking
- useful for disabling situational anxiety
buspirone (Buspar)
miscellaneous antianxiety
- partial agonist for serotonin 1A (5HT) receptor
- produces only anxiolytic effects, no CNS depression
- no issues with dependence or withdrawal and no additive depression with ETOH
- Onset takes 1-3 weeks limiting its use